COM:ROCKETPHARMA

Rocket Pharmaceuticals

Stock

USD

Last Close

10.12

14/02 21:00

Market Cap

1.94B

Beta: -

Volume Today

832.17K

Avg: -

Overview Metrics Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue
cost of revenue										7.10M -
gross profit										-7.10M -
selling and marketing expenses										-1.72M -
general and administrative expenses	2.11M -	7.84M 271.31%	9.89M 26.17%	12.54M 26.78%	17.89M 42.59%	17.53M 2.00%	27.92M 59.29%	41.77M 49.61%	58.77M 40.70%	73.32M 24.75%
selling general and administrative expenses	2.11M -	7.84M 271.31%	9.89M 26.17%	12.54M 26.78%	17.89M 42.59%	17.53M 2.00%	27.92M 59.29%	41.77M 49.61%	58.77M 40.70%	71.59M 21.81%
research and development expenses	5.59M -	12.55M 124.50%	31.98M 154.78%	14.19M 55.63%	53.27M 275.33%	58.62M 10.05%	106.38M 81.47%	125.48M 17.95%	165.57M 31.95%	180.97M 9.30%
other expenses					186K -	-250K 234.41%		-1M -	-500K 50%
cost and expenses	7.70M -	20.40M 164.75%	41.88M 105.33%	26.74M 36.16%	70.97M 165.44%	75.90M 6.95%	134.30M 76.94%	166.25M 23.79%	223.84M 34.64%	259.66M 16.00%
operating expenses	7.70M -	20.40M 164.75%	41.88M 105.33%	26.74M 36.16%	70.97M 165.44%	75.90M 6.95%	134.30M 76.94%	166.25M 23.79%	223.84M 34.64%	252.56M 12.83%
interest expense	980K -	1.23M 25.51%	1.42M 15.28%	3.58M 152.40%	5.24M 46.35%	4.78M 8.69%	7.55M 57.79%	5.89M 21.97%	1.91M 67.58%	1.88M 1.78%
ebitda	-7.70M -	-20.26M 163.01%	-41.27M 103.67%	-25.72M 37.68%	-68.95M 168.10%	-72.06M 4.51%	-131.01M 81.80%	-163.18M 24.56%	-213.69M 30.95%	-252.56M 18.19%
operating income	-7.70M -	-20.40M 164.75%	-41.88M 105.33%	-26.74M 36.16%	-71.16M 166.13%	-76.15M 7.02%	-134.30M 76.36%	-167.25M 24.53%	-224.34M 34.14%	-259.66M 15.74%
depreciation and amortization		45K -	169K 275.56%	200K 18.34%	330K 65%	4.09M 1,139.39%	3.29M 19.44%	4.07M 23.46%	10.65M 161.92%	7.10M 33.38%
total other income expenses net	-847K -	-46.45M 5,383.47%	-975K 97.90%	-2.76M 183.08%	801K 129.02%	-1.12M 239.70%	-5.40M 382.31%	-1.82M 66.26%	2.48M 236.19%	14.06M 467.10%
income before tax	-9.53M -	-67.98M 613.27%	-42.85M 36.96%	-29.50M 31.17%	-74.52M 152.63%	-77.27M 3.69%	-139.70M 80.79%	-169.07M 21.02%	-221.86M 31.23%	-245.59M 10.70%
income tax expense		1.23M -	443K 63.98%	819K 84.88%	2.68M 226.86%	5.96M 122.56%	6.97M 16.94%	516K 92.59%	-2.48M 580.62%
net income	-9.53M -	-67.98M 613.27%	-42.85M 36.96%	-29.50M 31.17%	-74.52M 152.63%	-83.23M 11.69%	-146.67M 76.22%	-169.59M 15.63%	-219.38M 29.36%	-245.59M 11.95%
weighted average shs out	3.42M -	4.58M 34.02%	6.68M 46.00%	6.77M 1.22%	39.38M 482.04%	49.01M 24.46%	55.38M 13.00%	63.24M 14.18%	68.15M 7.77%	84.01M 23.27%
weighted average shs out dil	3.42M -	4.58M 34.02%	6.68M 46.00%	6.77M 1.22%	39.38M 482.04%	49.01M 24.46%	55.38M 13.00%	63.24M 14.18%	68.15M 7.77%	84.01M 23.27%
eps	-2.79 -	-14.85 432.26%	-6.41 56.84%	-4.36 31.98%	-1.89 56.65%	-1.70 10.05%	-2.65 55.88%	-2.68 1.13%	-3.22 20.15%	-2.92 9.32%
epsdiluted	-2.79 -	-14.85 432.26%	-6.41 56.84%	-4.36 31.98%	-1.89 56.65%	-1.70 10.05%	-2.65 55.88%	-2.68 1.13%	-3.22 20.15%	-2.92 9.32%

All numbers in USD (except ratios and percentages)